Top Markets
Coin of the day
Healthtech Solutions Inc. Healthtech Solutions Inc.

Healthtech Solutions Inc.

HLTT
Kedudukan dalam Saham #41764
Healthtech Solutions Inc. operates as a life sciences firm through its various... Healthtech Solutions Inc. operates as a life sciences firm through its various subsidiary companies. A primary area of their work involves creating innovative products for the treatment of both acute and chronic wounds, exemplified by AmnioBind. This specific offering is a placental membrane allograft designed to address severe burns and persistent wounds, such as diabetic foot ulcers. Beyond wound care, the company is also engaged in developing advanced ultrasound imaging technology that integrates artificial intelligence for image analysis, intended for applications in diagnosing and treating conditions affecting the chest and musculoskeletal system. Furthermore, Healthtech Solutions is pioneering software designed to electronically compare signals from a healthy heart rhythm with those from a damaged heart, aiming to derive a unique "curative waveform" signal. Established in 2018, the company's headquarters are located in Tuckahoe, New York.
Harga Saham
$0.0001
Disegerakkan terakhir: 2025-11-25
Modal Pasaran
$10.66K
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan Healthtech Solutions Inc. (HLTT)

Kategori

Pendapatan untuk Healthtech Solutions Inc. (HLTT)
Pendapatan pada 2026 TTM: 0
Menurut laporan kewangan terkini Healthtech Solutions Inc., pendapatan semasa syarikat ialah 0. Pada tahun 2026, syarikat memperoleh pendapatan sebanyak 0, sama dengan pendapatan pada tahun 2026 yang berjumlah 0. Pendapatan yang dipaparkan di halaman ini adalah pendapatan sebelum faedah dan cukai atau dikenali sebagai EBIT.
Sejarah pendapatan bagi Healthtech Solutions Inc. dari 2026 hingga 2026
Pendapatan pada akhir setiap tahun
Tahun Pendapatan Ubah
Tidak cukup data untuk tarikh yang disediakan.
Pendapatan untuk syarikat atau pesaing serupa
Syarikat Pendapatan Perbezaan Pendapatan Negara
$2.04B -
US
$222.34M -
AU
$295.53M -
US
$-259.89M -
US
- -
US